4//SEC Filing
Arcara Jeffrey 4
Accession 0001610717-24-000106
CIK 0001626971other
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 5:57 PM ET
Size
5.3 KB
Accession
0001610717-24-000106
Insider Transaction Report
Form 4
Arcara Jeffrey
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-02-28+400,000→ 400,000 totalExercise: $2.30Exp: 2034-02-28→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to 1/36th of the shares subject to the option in successive, equal monthly installments measured from February 2, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Corvus Pharmaceuticals, Inc.
CIK 0001626971
Entity typeother
Related Parties
1- filerCIK 0002010430
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 5:57 PM ET
- Size
- 5.3 KB